These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25928700)

  • 21. Psychiatric symptoms of children and adolescents with juvenile neuronal ceroid lipofuscinosis.
    Bäckman ML; Santavuori PR; Aberg LE; Aronen ET
    J Intellect Disabil Res; 2005 Jan; 49(Pt 1):25-32. PubMed ID: 15634309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zonisamide produces weight loss in psychotropic drug-treated psychiatric outpatients.
    Lim J; Ko YH; Joe SH; Han C; Lee MS; Yang J
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec; 35(8):1918-21. PubMed ID: 21803114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is the association of history of psychiatric disorders with takotsubo syndrome partially mediated by the underlying psychotropic drug therapy?
    Madias JE
    Int J Cardiol; 2016 Oct; 220():307-9. PubMed ID: 27390946
    [No Abstract]   [Full Text] [Related]  

  • 24. A Review of Methods for Monitoring Adverse Events in Pediatric Psychopharmacology Clinical Trials.
    Coates M; Spanos M; Parmar P; Chandrasekhar T; Sikich L
    Drug Saf; 2018 May; 41(5):465-471. PubMed ID: 29318515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reliability of a modified medication appropriateness index in ambulatory older persons.
    Fitzgerald LS; Hanlon JT; Shelton PS; Landsman PB; Schmader KE; Pulliam CC; Williams ME
    Ann Pharmacother; 1997 May; 31(5):543-8. PubMed ID: 9161645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review of self-report medication side effect questionnaires for mental health patients.
    Ashoorian D; Davidson R; Rock D; Gudka S; Clifford R
    Psychiatry Res; 2014 Nov; 219(3):664-73. PubMed ID: 25034414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical utility of pharmacogenetic testing in children and adolescents with severe mental disorders.
    Blasco-Fontecilla H
    J Neural Transm (Vienna); 2019 Jan; 126(1):101-107. PubMed ID: 29626260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reliability and validity of the Japanese version of the Recovery Assessment Scale (RAS) for people with chronic mental illness: scale development.
    Chiba R; Miyamoto Y; Kawakami N
    Int J Nurs Stud; 2010 Mar; 47(3):314-22. PubMed ID: 19679304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medication for young children with mental illnesses.
    Pottier M
    J Psychosoc Nurs Ment Health Serv; 2007 Oct; 45(10):13; author reply 13, 23. PubMed ID: 17992769
    [No Abstract]   [Full Text] [Related]  

  • 30. Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups.
    Curran S; Turner D; Musa S; Wattis J
    Int J Geriatr Psychiatry; 2005 Sep; 20(9):842-7. PubMed ID: 16116576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychopharmacology in adolescent medicine.
    Scharf MA; Williams TP
    Adolesc Med Clin; 2006 Feb; 17(1):165-81. PubMed ID: 16473299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Practical Approach to Avoiding Cardiovascular Adverse Effects of Psychoactive Medications.
    Brouillette J; Nattel S
    Can J Cardiol; 2017 Dec; 33(12):1577-1586. PubMed ID: 29173600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychotropic medication in the elderly. A survey of prescribing and clinical outcome.
    Olsen RB; Gydesen SU; Kristensen M; Eschen FT; Sørensen C; Hasle H; Lund S; Baastrup PC; Gylding-Sabroe J
    Dan Med Bull; 1990 Oct; 37(5):455-9. PubMed ID: 1980241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reliability of adverse drug reaction assessment in psychiatric inpatients.
    Grohmann R; Dirschedl P; Scherer J; Schmidt LG; Wunderlich O
    Eur Arch Psychiatry Neurol Sci; 1985; 235(3):158-63. PubMed ID: 2868897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Brown Assessment of Beliefs Scale: reliability and validity.
    Eisen JL; Phillips KA; Baer L; Beer DA; Atala KD; Rasmussen SA
    Am J Psychiatry; 1998 Jan; 155(1):102-8. PubMed ID: 9433346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of mental illness and psychotropic medications on sexual functioning: the evidence and management.
    Clayton AH; Balon R
    J Sex Med; 2009 May; 6(5):1200-11; quiz 1212-3. PubMed ID: 19453927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unravelling subjectivity, embodied experience and (taking) psychotropic medication.
    Flore J; Kokanović R; Callard F; Broom A; Duff C
    Soc Sci Med; 2019 Jun; 230():66-73. PubMed ID: 30978572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prescribing psychotropic medications for elderly patients.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2009 Nov; 47(11):17-20. PubMed ID: 19921758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychotropic medications and HIV.
    Thompson A; Silverman B; Dzeng L; Treisman G
    Clin Infect Dis; 2006 May; 42(9):1305-10. PubMed ID: 16586391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical validation of the Aarhus Side effect Assessment Questionnaire(ASAQ).
    Kølbæk P; Thorgaard MV; Grooss AS; Selvanathan T; Larsen SF; Speed M; Dines D; Østergaard SD
    J Psychopharmacol; 2022 Apr; 36(4):507-515. PubMed ID: 35234056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.